Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Somnomed.
RELATED STOCKHEAD STORIES
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Experts
Scopo’s powerplays: Investors love a result, until they don’t
News
What ASX investors should look for in a COVID-19 earnings season
Food & Agriculture
Economic recovery post-COVID, the five sectors that will lead the charge
Health & Biotech
These are the life sciences small caps almost unscathed by COVID-19
Experts
Scopo’s powerplays: It just won’t go down!
Health & Biotech
The health stocks still taking a hit from COVID-19
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
Health & Biotech
Check up: Sometimes no news is good news
Experts
Scopo’s health powerplays: You’re all going to the pot, literally
Health & Biotech
Night terrors are over for sleep stock Somnomed
Director Trades
Directors Trades: This anti-snoring device maker needed capital to survive COVID-19; one director put in $3.7m
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Somnomed spins fairytale of a sleep cure in half-year results
Health & Biotech
Health: Oventus isn’t sleeping on the job because it’s making too much money
Health & Biotech
Dr Boreham’s Crucible: ResMed turbo-charges its sleep apnoea devices, races into new markets
Stockhead TV
